News

News

MicroPort® CardioFlow Attends the Fifth Edition of PCR-CIT China Chengdu Valves -

The fifth edition of PCR-CIT China Chengdu Valves under the joint orga...

MicroPort® Won APQO Innovation Class Award 2019 -

The 25th Asia Pacific Quality Organization (APQO) International Confer...

MicroPort® Wins First Edition of "Shanghai Municipality Intellectual Property Innovation Award" -

On October 21, 2019, MicroPort® won the first edition of Shanghai Muni...

MicroPort® Exhibits VitaFlow® Integrated Solution at Third Edition of China Structure Week -

On October 7-13, 2019, the China Structure Week 2019 and 3rd Edition o...

MicroPort® Firesorb® Pivotal Study (FUTURE III) Holds National Investigator Kick-off Meeting in Beijing -

On October12, 2019, FUTURE-III, a pivotal Study for Firesorb® Bioresor...

Endovastec™ Post-marketing Clinical Study of Minos® Abdominal Aortic Stent-Graft and Delivery System Noted in Shanghai -

On September 27, 2019, the Post-marketing Clinical Study of Minos® Abd...

Inauguration of MicroPort® Orthopedics' International Shared Services Center in Costa Rica -

MicroPort® Orthopedics' International Shared Services Center in Costa ...

MicroPort® CRM Announces First Implant in Japan of the New Eno™ Pacemaker Family, World's Smallest 1.5T & 3T MRI Conditional Pacemakers* -

MicroPort® CRM, which is a business unit of MicroPort Scientific Corpo...

MicroPort® CRM Japan Starts Direct Sales Operations in Japan and Launches the New ENO™ Pacemaker Family -

MicroPort® CRM Japan Co. Ltd. is pleased to announce it has started di...

MicroPort® Announces Interim Results for the Six Months Ended June 30, 2019 -

MicroPort Scientific Corporation (the "Company", or "MicroPort®", Stoc...

Endovastec™, a Subsidiary of MicroPort®, Listed on the STAR Market of the Shanghai Stock Exchange -

Shanghai MicroPort Endovascular MedTech Co., Ltd. ("Endovastec™", or "...

MicroPort® Orthopedics Announces Launch of its Evolution® NitrX™ Knee -

MicroPort® Orthopedics, a medical device company that develops and man...

VitaFlow® Transcatheter Aortic Valve and Delivery System Receives NMPA Approval -

On July 12th, Shanghai MicroPort CardioFlow Medtech Co., Ltd. ("MicroP...

MicroPort® EP Obtains Approval for OptimAblate™ Cardiac RF Generator from National Medical Products Administration of China (NMPA) -

Shanghai MicroPort EP MedTech Co., Ltd. (“MicroPort® EP”) recently obt...

Mr. Rodrigo Pérez Estrada Joins MicroPort® as Vice President Global Branding -

Shanghai, China - Rodrigo Pérez Estrada has recently joined MicroPort ...

MicroPort® Attends the 13th Oriental Congress of Cardiology (OCC 2019) -

Shanghai MicroPort Medcial (Group) Co., Ltd. (“MicroPort®”) presented ...